Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
eNq1mN9v2jAQx9/5K6K8kxBWSpkC1cZgQ2pVRos27aUyyVHMUjs92/zYXz+H0I1Ojroa/Bjb+d7Zd/7cyfHl5jHzVoCCctb1o6Dhe8ASnlL20PWnd8P6hX/Zq8VLsiIHy9pBI4iavpdkRIiuX8wGMyBMBN+vrz6B/h/Q79W8mM+WkMgX65SkWfCFiMU1yYs1XrziNPUeQS542vVzJXejXiwkai96a44/RU4SiMP9yOHs8v7scDwOC7H/UFUC8IqwB6MoMCvNRCECk30i4YHjtsLfd1baVExAcIUJjIlcjJGvaAqp0cScZAKsjMzX6S3gKgNZGDGKh8vkUViJkyXZTOBpZHb6g57ty42sN+pRu33WaJ03Ou1mu2NlCg+OyhwFvYkwuY9aUbvTjEJgYaL3TZBuLIMz5ihJ5igsVPRfZpYjOwhPr4Y/pSLPyDZYitz2qAgSPQ2o77+7jRQ7uENNpEyf2T/6TGVZ+Eavp3teOPK4wFGfKyYrsDGc2B5EnzMJm+qI2pFObva5SEGcTvYXZ2bKj9Uso4kt0zR1FAg5nYyqkXZSGnwkAqboDgffKEv5WpweM4dhdeR9viOlUTTHNLpvdi7Oo1bL+hb90DlUUWMGCnkOoQYQFcdwZcTm/Fii6LQ0Sz0n5enycdfq8IRkUNHs1C3pohPxuTdzlururlE5YRT9PLizzY+vCnB7u/s0StO0+yeyduh1wXOdjZWOvz23yyvupA1WaEbHQspcvA/D9XodLIioC6JPKZjj6dl+UE/ddeFOinbZxJR8dOT6rCx8bwuR7VV7rawf26ru/9+3xEYbEhUcEYuSys7YORqcHsd/+1Rnbo9f4MOdmV1PSSTlzFWro2ZGxeMKgI4rG6IGxM18TiteRSrzMg7LF5leLQ6L15he7TdF9OaC
mw8WvaNmTTneJNjr
